502 related articles for article (PubMed ID: 25551588)
1. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.
Braoudaki M; Lambrou GI; Giannikou K; Milionis V; Stefanaki K; Birks DK; Prodromou N; Kolialexi A; Kattamis A; Spiliopoulou CA; Tzortzatou-Stathopoulou F; Kanavakis E
J Hematol Oncol; 2014 Dec; 7():96. PubMed ID: 25551588
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression profiles in pediatric dysembryoplastic neuroepithelial tumors.
Braoudaki M; Lambrou GI; Papadodima SA; Stefanaki K; Prodromou N; Kanavakis E
Med Oncol; 2016 Jan; 33(1):5. PubMed ID: 26698155
[TBL] [Abstract][Full Text] [Related]
3. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics and Regression Analyses Manifest Tumor-Specific miRNA Expression Dynamics in Pediatric Embryonal Malignancies.
Braoudaki M; Koutsouris DD; Kouris I; Paidi A; Koutsouri G; George Lambrou I
Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():5834-5837. PubMed ID: 30441662
[TBL] [Abstract][Full Text] [Related]
5. miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas.
Braoudaki M; Lambrou GI; Giannikou K; Papadodima SA; Lykoudi A; Stefanaki K; Sfakianos G; Kolialexi A; Tzortzatou-Stathopoulou F; Tzetis M; Kitsiou-Tzeli S; Kanavakis E
Tumour Biol; 2016 Jul; 37(7):9887-97. PubMed ID: 26813564
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of SUN2, a novel tumor suppressor, mediates miR-221/222-induced malignancy in central nervous system embryonal tumors.
Hsieh TH; Chien CL; Lee YH; Lin CI; Hsieh JY; Chao ME; Liu DJ; Chu SS; Chen W; Lin SC; Ho DM; Liu RS; Lin CH; Wong TT; Wang HW
Carcinogenesis; 2014 Oct; 35(10):2164-74. PubMed ID: 24832085
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic role of microRNAs in brain tumors.
Pang JC; Kwok WK; Chen Z; Ng HK
Acta Neuropathol; 2009 Jun; 117(6):599-611. PubMed ID: 19343354
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown.
Braoudaki M; Lambrou GI
J Hematol Oncol; 2015 Feb; 8():6. PubMed ID: 25652781
[TBL] [Abstract][Full Text] [Related]
9. hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors.
Fan X; Wang Y; Kratz J; Brat DJ; Robitaille Y; Moghrabi A; Perlman EJ; Dang CV; Burger PC; Eberhart CG
Am J Pathol; 2003 Jun; 162(6):1763-9. PubMed ID: 12759234
[TBL] [Abstract][Full Text] [Related]
10. PLK1-associated microRNAs are correlated with pediatric medulloblastoma prognosis.
Pezuk JA; Brassesco MS; de Oliveira RS; Machado HR; Neder L; Scrideli CA; Tone LG
Childs Nerv Syst; 2017 Apr; 33(4):609-615. PubMed ID: 28283778
[TBL] [Abstract][Full Text] [Related]
11. Survey of MicroRNA expression in pediatric brain tumors.
Birks DK; Barton VN; Donson AM; Handler MH; Vibhakar R; Foreman NK
Pediatr Blood Cancer; 2011 Feb; 56(2):211-6. PubMed ID: 21157891
[TBL] [Abstract][Full Text] [Related]
12. Aberrantly expressed microRNAs and their implications in childhood central nervous system tumors.
Pezuk JA; Salomão KB; Baroni M; Pereira CA; Geron L; Brassesco MS
Cancer Metastasis Rev; 2019 Dec; 38(4):813-828. PubMed ID: 31797180
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons.
Shalaby T; Fiaschetti G; Baumgartner M; Grotzer MA
Int J Mol Sci; 2014 Nov; 15(11):21554-86. PubMed ID: 25421247
[TBL] [Abstract][Full Text] [Related]
14. miR-367 as a therapeutic target in stem-like cells from embryonal central nervous system tumors.
Kaid C; Jordan D; Bueno HMS; Araujo BHS; Assoni A; Okamoto OK
Mol Oncol; 2019 Dec; 13(12):2574-2587. PubMed ID: 31402560
[TBL] [Abstract][Full Text] [Related]
15. Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors.
Hsieh TH; Liu YR; Chang TY; Liang ML; Chen HH; Wang HW; Yen Y; Wong TT
Neuro Oncol; 2018 Mar; 20(4):519-530. PubMed ID: 29036598
[TBL] [Abstract][Full Text] [Related]
16. Expression of epidermal growth factor receptor and HER-2 in pediatric embryonal brain tumors.
Patereli A; Alexiou GA; Stefanaki K; Moschovi M; Doussis-Anagnostopoulou I; Prodromou N; Karentzou O
Pediatr Neurosurg; 2010; 46(3):188-92. PubMed ID: 20962551
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors.
Han YP; Ma CK; Wang SQ; Enomoto A; Zhao Y; Takahashi M; Ma J
J Neurooncol; 2014 Sep; 119(2):343-51. PubMed ID: 24879375
[TBL] [Abstract][Full Text] [Related]
18. Embryonal Tumors of the Central Nervous System with Multilayered Rosettes and Atypical Teratoid/Rhabdoid Tumors.
Kamenova M; Kaneva R; Genova K; Gabrovsky N
Adv Exp Med Biol; 2023; 1405():225-252. PubMed ID: 37452940
[TBL] [Abstract][Full Text] [Related]
19. Cross platform analysis of methylation, miRNA and stem cell gene expression data in germ cell tumors highlights characteristic differences by tumor histology.
Poynter JN; Bestrashniy JR; Silverstein KA; Hooten AJ; Lees C; Ross JA; Tolar J
BMC Cancer; 2015 Oct; 15():769. PubMed ID: 26497383
[TBL] [Abstract][Full Text] [Related]
20. Embryonal central nervous system neoplasms arising in infants and young children: a pediatric brain tumor consortium study.
McLendon RE; Adekunle A; Rajaram V; Koçak M; Blaney SM
Arch Pathol Lab Med; 2011 Aug; 135(8):984-93. PubMed ID: 21809989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
